Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | +5.54% | +11.73% | +104.52% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+104.52% | 677M | |
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+40.80% | 39.03B | |
-11.17% | 26.86B | |
+14.28% | 26.75B | |
-21.40% | 19.03B | |
+0.96% | 12.28B | |
+25.64% | 12.26B | |
+27.04% | 12.04B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Transcript : Taysha Gene Therapies, Inc., Q2 2022 Earnings Call, Aug 11, 2022